Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of CLS2901C Chondrocyte Sheet Transplantation in Knee Osteoarthritis
jRCT2033230587Phase 3Recruiting
- Sponsor
- CellSeed
- Start
- Oct 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of CLS2901C in knee osteoarthritis (OA), sponsored by CellSeed. Primary endpoint: KOOS4 score change at Week 52. Started Oct 2025; status: recruiting.
02
Drugs
CLS2901C
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2033230587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033230587.